Pacira Pharmaceuticals (PCRX) PT Lifted to $133 at Wedbush

February 25, 2015 6:57 AM

Wedbush analyst Liana Moussatos reiterated an Outperform rating and boosted her price target on Pacira Pharmaceuticals (NASDAQ: PCRX) to $133.00 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found